Chr Hansen main owner completes sale to Novo fund

COPENHAGEN, March 29 Thu Mar 29, 2012 6:04am EDT

COPENHAGEN, March 29 (Reuters) - The biggest shareholder in Danish food ingredients maker Chr. Hansen has sold a 25.7 percent stake to Novo A/S, cutting its holdings to 0.09 percent in line with a January announcement, Chr. Hansen said on Thursday.

Financiere Star 1 S.A., a fund controlled by private equity investment firm PAI Partners, sold about 35.42 million shares in Chr. Hansen Holding A/S to Novo A/S, Chr. Hansen said.

The companies had announced the deal on Jan. 11. .

Novo A/S is a foundation-owned company and the main shareholder in Danish drugmaker Novo Nordisk A/S and industrial enzymes maker Novozymes A/S.

Novo A/S said in January it aimed to be a long-term minority shareholder in Chr. Hansen and had no intention to take control of the company. (Reporting by John Acher, editing by Kristian Balsgaard Mortensen)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.